AAAAAA
Results:
1-7
|
Results: 7
Authors:
Ramachandra, M
Rahman, A
Zou, AH
Vaillancourt, M
Howe, JA
Antelman, D
Sugarman, B
Demers, GW
Engler, H
Johnson, D
Shabram, P
Citation: M. Ramachandra et al., Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy, NAT BIOTECH, 19(11), 2001, pp. 1035-1041
Authors:
De Vleeschauwer, M
Vaillancourt, M
Goudreau, N
Guindon, Y
Gravel, D
Citation: M. De Vleeschauwer et al., Design and synthesis of a new sialyl Lewis X mimetic: How selective are the selectin receptors?, BIOORG MED, 11(9), 2001, pp. 1109-1112
Authors:
Hirai, M
Kelsey, LS
Vaillancourt, M
Maneval, DC
Watanabe, T
Talmadge, JE
Citation: M. Hirai et al., Purging of human breast cancer cells from stem cell products with an adenovirus containing p53, CANC GENE T, 7(2), 2000, pp. 197-206
Authors:
Vaillancourt, M
Chen, JW
Fortier, G
Belanger, D
Citation: M. Vaillancourt et al., Electrochemical and enzymatic studies of electron transfer mediation by ferrocene derivatives with Nafion-glucose oxidase electrodes, ELECTROANAL, 11(1), 1999, pp. 23-31
Authors:
Vaillancourt, M
Irlbeck, D
Smith, T
Coombs, RW
Swanstrom, R
Citation: M. Vaillancourt et al., The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance, AIDS RES H, 15(4), 1999, pp. 355-363
Authors:
Vaillancourt, M
Irlbeck, D
Smith, T
Coombs, RW
Swanstrom, R
Citation: M. Vaillancourt et al., The HIV-1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance (vol 15, pg 355, 1999), AIDS RES H, 15(10), 1999, pp. 949-949
Authors:
Hirai, M
Kelsey, LS
Maneval, DC
Vaillancourt, M
Talmadge, JE
Citation: M. Hirai et al., Adenovirus p53 purging for human breast cancer stem cell products, ACT HAEMAT, 101(2), 1999, pp. 97-105
Risultati:
1-7
|